Results 111 to 120 of about 2,500 (166)

Synthesis and Anticancer Evaluation of New 1,3,4-Oxadiazole Derivatives. [PDF]

Pharmaceuticals (Basel), 2021
Stecoza CE, Nitulescu GM, Draghici C, Caproiu MT, Olaru OT, Bostan M, Mihaila M.   +6 more
europepmc   +1 more source

Synthesis of designed new 1,3,4-oxadiazole functionalized pyrano [2,3-f] chromene derivatives and their antimicrobial activities. [PDF]

Heliyon
Alatawi K, Qarah AF, Alharbi H, Alisaac A, Abualnaja MM, Attar RMS, Alsoliemy A, El-Metwaly NM.   +7 more
europepmc   +1 more source

Synthesis, electrochemical properties, and antioxidant activity of sterically hindered catechols with 1,3,4-oxadiazole, 1,2,4-triazole, thiazole or pyridine fragments. [PDF]

Beilstein J Org Chem
Burmistrova DA, Galustyan A, Pomortseva NP, Pashaeva KD, Arsenyev MV, Demidov OP, Kiskin MA, Poddel'sky AI, Berberova NT, Smolyaninov IV.   +9 more
europepmc   +1 more source

Synthesis and Antitumor Activity Evaluation of Novel Echinatin Derivatives with a 1,3,4-Oxadiazole Moiety. [PDF]

Int J Mol Sci
Tian X, Sun Z, Zhong Y, Yang H, Cheng M, Liu Y.   +5 more
europepmc   +1 more source

Synthesis, characterization, biological evaluation, and molecular docking studies of new 1,3,4-oxadiazole-thioether derivative as antioxidants and cytotoxic agents. [PDF]

Heliyon
Shiferaw DG, Kalluraya B.
europepmc   +1 more source

Sensing of Co²⁺ and Cu²⁺ Ions Using Dimethylamino-functionalized Poly(azomethine-1,3,4-oxadiazole)s. [PDF]

J Fluoresc
Homocianu M, Hamciuc E, Hamciuc C.
europepmc   +1 more source

Design and synthesis of novel 2-(2-(4-bromophenyl)quinolin-4-yl)-1,3,4-oxadiazole derivatives as anticancer and antimicrobial candidates: in vitro and in silico studies. [PDF]

RSC Adv
Ryad N, Elmaaty AA, Selim S, Almuhayawi MS, Al Jaouni SK, Abdel-Aziz MS, Alqahtani AS, Zaki I, Abdel Ghany LMA.   +8 more
europepmc   +1 more source

Synthesis, biological evaluation, and molecular docking of novel ferulic acid derivatives containing a 1,3,4-oxadiazole thioether and trifluoromethyl pyrimidine skeleton. [PDF]

RSC Adv
An J, Pan N, Liu C, Chen H, Fei Q, Gan X, Wu W.   +6 more
europepmc   +1 more source

Conversion of raltegravir carrying a 1,3,4-oxadiazole ring to a hydrolysis product upon pH changes decreases its antiviral activity. [PDF]

PNAS Nexus
Nakamura T, Okumura M, Takamune N, Hirotsu T, Sugiura M, Yasunaga J, Nakata H.   +6 more
europepmc   +1 more source